These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20508384)

  • 61. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies of circulating parathyroid hormone in man by a homologous amino-terminal specific radioimmunoassay.
    Konagaya Y; Konagaya M; Takatsuki K; Tomita A; Watanabe S; Noda T; Katsuragi S
    Jpn J Med; 1984 Aug; 23(3):199-204. PubMed ID: 6492483
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR; Perlmutter S; Aloia JF
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib).
    Molinaro A; Tiosano D; Takatani R; Chrysis D; Russell W; Koscielniak N; Kottler ML; Agretti P; De Marco G; Ahtiainen P; Christov M; Mäkitie O; Tonacchera M; Jüppner H
    J Bone Miner Res; 2015 May; 30(5):906-12. PubMed ID: 25403028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b.
    Srivastava T; Krudys J; Mardis NJ; Sebestyen-VanSickle J; Alon US
    Pediatr Nephrol; 2016 May; 31(5):795-800. PubMed ID: 26628282
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calcium and vitamin d supplementation in postmenopausal women.
    Aloia JF; Dhaliwal R; Shieh A; Mikhail M; Islam S; Yeh JK
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1702-9. PubMed ID: 24064695
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients.
    Sorva A; Välimäki M; Risteli J; Risteli L; Elfving S; Takkunen H; Tilvis R
    Eur J Clin Invest; 1994 Dec; 24(12):806-12. PubMed ID: 7705374
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
    Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cloning and characterization of kidney-specific promoter of human PTH/PTHrP receptor gene: absence of mutation in patients with pseudohypoparathyroidism type Ib.
    Fukumoto S; Suzawa M; Kikuchi T; Matsumoto T; Kato S; Fujita T
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):41-7. PubMed ID: 9723884
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The resistance to parathyroid hormone of fibroblasts from some patients with type Ib pseudohypoparathyroidism is reversible with dexamethasone.
    Silve C; Suarez F; el Hessni A; Loiseau A; Graulet AM; Gueris J
    J Clin Endocrinol Metab; 1990 Sep; 71(3):631-8. PubMed ID: 2168431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Suppression of parathyroid hormone inhibitory activity of plasma in pseudohypoparathyroidism type I by i.v. calcium.
    Loveridge N; Fischer JA; Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Endocrinol (Oxf); 1986 May; 24(5):549-54. PubMed ID: 3791650
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Separation of inhibitory activity from biologically active parathyroid hormone in patients with pseudohypoparathyroidism type I.
    Loveridge N; Tschopp F; Born W; Devogelaer JP; Nagant de Deuxchaisnes C; Fischer JA
    Biochim Biophys Acta; 1986 Nov; 889(2):117-22. PubMed ID: 3778943
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.
    Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S
    Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Parathyroid hormone and vitamin D receptors.
    Spiegel AM; Marx SJ
    Clin Endocrinol Metab; 1983 Mar; 12(1):221-41. PubMed ID: 6303646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
    Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women.
    Bonjour JP; Benoit V; Payen F; Kraenzlin M
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2915-21. PubMed ID: 23653431
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
    Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
    Yasuda T; Nakajima H
    Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.